Best Longevity Supplements (2026): What the Evidence Supports

Disclosure: Vital Signs Today may earn a commission if you buy through links on this page, at no extra cost to you. This does not influence our evidence-based assessments. We are not a medical provider; talk to a clinician before acting on test results.

Quick take: No pill is proven to extend human lifespan. The supplements with real human trial evidence behind them solve narrow, specific problems: omega-3 if your intake is low, vitamin D if you are deficient, magnesium for blood pressure, creatine for muscle, fiber for cholesterol. The glamorous “anti-aging” molecules you see on podcasts (NMN, NR, resveratrol, spermidine, urolithin A, taurine) almost all rest on mouse and petri-dish data. In rigorous human trials they tend to move a biomarker and miss the outcome that matters. This guide sorts the field by evidence tier, honestly, and shows you a cheaper move than guessing: test the markers that actually track with aging, change one thing, and re-test.

Disclosure: Vital Signs Today may earn a commission if you buy through links on this page, at no extra cost to you. This does not influence our evidence-based assessments. We are not a medical provider; talk to a clinician before acting on test results.

Quick take: what is worth it vs hype

Here is the whole field in one table, sorted by how much human evidence stands behind it. “Human RCT” means randomized, placebo-controlled trials in people, measuring an outcome people care about. “Animal/mechanistic” means it works in mice, worms, or cells, and the human story is still a hope.

Supplement	Evidence tier	What it actually does in humans	Verdict
Omega-3 (EPA/DHA)	Strong	Lowers triglycerides; high-dose prescription EPA cut cardiac events in high-risk patients	Worth it if fish intake is low
Vitamin D	Strong (if deficient)	Corrects deficiency; signal for fewer autoimmune diseases	Worth it if your level is low
Magnesium	Strong (modest)	Small drop in blood pressure, mainly in people who are low or hypertensive	Cheap, low-risk, modest payoff
Creatine monohydrate	Strong	More lean mass and strength with resistance training; cognition still unproven	Worth it if you lift
Fiber / psyllium	Strong	Lowers LDL cholesterol; high fiber diets track with lower mortality	Worth it; food first
NMN / NR (NAD+ boosters)	Promising but thin	Raises blood NAD+; functional trials mostly null	Experimental
Resveratrol	Hyped, weak	Barely absorbed; human trials disappointing	Skip
Spermidine	Hyped, weak	Memory trial was null	Skip (eat the food instead)
Urolithin A	Promising but thin	Missed primary endpoints in both big muscle trials	Experimental
CoQ10 / ubiquinol	Niche	One good heart-failure trial; statin myopathy claim unsupported	Specific cases only
Taurine	Hyped, unproven	Extended life in mice; human premise contradicted in 2025	Skip for longevity
Rapamycin	Prescription drug	Extends mouse lifespan; human longevity unproven	Not a supplement; physician only

The short version: the boring basics earn their place, the exciting molecules do not yet, and the single most useful thing you can buy in this category is not a supplement at all. It is a blood test that tells you which of these you actually need.

How we rank supplement evidence

The supplement aisle blurs three very different things, and most marketing depends on you not noticing the difference.

Mechanistic data is the weakest. A molecule does something interesting in a test tube: it activates a pathway, raises a marker, switches a gene on. Interesting, but a cell in a dish is not a person.

Animal data is one step up. The compound extends lifespan in worms, flies, or mice, or improves some marker in a monkey. This is where almost every “longevity” headline comes from. The problem is brutal and consistent: most things that extend mouse lifespan do nothing measurable in humans, and the doses used in mice often do not translate to a human pill.

Human randomized controlled trials (RCTs) are the gold standard. People are randomly assigned to the supplement or a placebo, neither they nor the researchers know who got what, and a real outcome is measured. This is the only tier that should move your money, and it is the tier where the glamorous molecules go quiet.

One more trap worth naming: biomarker change is not outcome change. A supplement can reliably raise your NAD+ level or your mitophagy markers and still do nothing for your strength, your insulin sensitivity, or your lifespan. Raising the number on a lab sheet is easy. Changing how you age is the hard part, and that is where the rigorous trials keep coming back empty. We also weight who funded the trial. A surprising share of the positive human studies on the hyped molecules were paid for by the company selling them.

With that lens, here is the field by tier.

Strong evidence: the supplements that earn their place

Omega-3 (EPA and DHA): the strongest everyday case, with an honest asterisk

Omega-3 has the deepest human evidence base of anything in this guide, but the headline you have heard is usually oversold. The strongest positive trial, REDUCE-IT (New England Journal of Medicine, 2019), cut major cardiovascular events by about 25 percent in roughly 8,000 statin-treated, high-risk patients. The catch: it tested a prescription drug, icosapent ethyl, at 4 grams a day of purified EPA, not the fish oil capsule in your cabinet. Different molecule, different dose, and an unresolved debate about whether the mineral-oil placebo inflated the benefit.

When researchers tested a normal over-the-counter dose, the picture flattened. The VITAL trial (25,871 healthy adults, about 840 mg EPA plus DHA daily) was essentially null on its primary endpoints of major cardiovascular events and total cancer. There was a secondary signal for fewer heart attacks, but the hard primary outcomes did not move. Translation: at supplement doses in already-healthy people, omega-3 is not a proven life-extender. Its clearest role is for people whose fish intake is genuinely low, or under medical supervision at high doses for high triglycerides.

There is also a real safety nuance the supplement industry rarely mentions: higher-dose fish oil raises the risk of atrial fibrillation. A pooled analysis found the risk climbed with dose, roughly a 12 percent relative increase below 1 gram a day but around a 50 percent increase at 1.8 to 4 grams. Oddly, eating fish and having higher omega-3 blood levels tracks with lower atrial fibrillation, while the high-dose capsules push it up.

If you supplement, look for third-party testing (IFOS or similar) and a meaningful EPA/DHA dose printed on the label, not just “fish oil 1000mg,” which tells you nothing about the active fraction.

Vitamin D: powerful if you are deficient, quiet if you are not

Vitamin D is the clearest example of “it depends who you are.” The same VITAL trial that tested omega-3 also tested 2,000 IU of vitamin D daily for over five years. Cancer incidence: null. Major cardiovascular events: null. All-cause mortality: null. The most credible positive finding was a roughly 22 percent reduction in new autoimmune diseases (rheumatoid arthritis, psoriasis, autoimmune thyroid disease and others), a signal that strengthened over seven years of follow-up. There was also a cancer-mortality signal that became significant only when the first two years were excluded, consistent with a slow latency effect.

The honest takeaway: supplementing vitamin D in people who are already replete shows little outcome benefit. The real value is in correcting genuine deficiency, which is common in people with little sun exposure, darker skin, obesity, older age, or who live at higher latitudes through winter. A maintenance dose of 1,000 to 2,000 IU a day is reasonable and well-studied. Chronic mega-dosing is not benign: some high-dose trials actually showed more falls and fractures. This is a supplement to take based on a blood level, not a guess.

Magnesium: modest, cheap, and real

Magnesium will not transform your healthspan, but the blood pressure data is solid. A meta-analysis of 38 randomized trials (median dose around 365 mg elemental magnesium) found systolic pressure dropped about 2.8 mmHg and diastolic about 2.0 mmHg. Small on average, larger in the people who need it most: those already on blood pressure medication or with low magnesium to begin with saw bigger drops. For glucose, magnesium modestly lowered fasting glucose but barely touched HbA1c, and again the benefit concentrated in people who were deficient or diabetic.

The popular “magnesium for sleep” claim is far softer than the marketing. The supporting evidence is three small trials in older adults, rated low quality, showing people fell asleep about 17 minutes faster, with a non-significant change in total sleep time. Plausible, cheap, low-risk, but not well-proven. On forms: glycinate and citrate absorb better and are gentler on the gut than oxide, which is poorly absorbed and acts more like a laxative. Watch out if you have kidney impairment.

Creatine monohydrate: not just for bodybuilders

Creatine is one of the most replicated supplements in all of sports and aging science, and it is dirt cheap. In older adults, a meta-analysis of 22 studies found that creatine combined with resistance training added roughly 1.2 to 1.4 kg of lean mass and improved strength compared with training alone. For anyone worried about age-related muscle loss, that is a genuine, repeatable effect, as long as you are also lifting weights. Creatine without training does much less.

The cognition and “brain energy” story is promising but not established. A 2024 meta-analysis suggested memory benefits, but European regulators reviewed the same data and found the pooling methods flawed, declining to endorse the conclusion. File brain benefits under “maybe, watch this space.”

On safety, the “creatine wrecks your kidneys” belief is a myth for healthy people. It stems from creatine mechanically raising creatinine, a kidney marker, without causing actual damage. Standard doses of 3 to 5 grams a day of plain monohydrate show no kidney or liver harm in healthy adults. Skip the expensive “advanced” forms; monohydrate is the only one with real evidence. People with existing kidney disease should clear it with a doctor.

Fiber and psyllium: the cholesterol tool hiding in plain sight

Psyllium is one of the few supplements with reliable, dose-responsive RCT evidence for lowering cholesterol. A meta-analysis of 28 trials found that about 10 grams a day lowered LDL by roughly 13 mg/dL, along with smaller drops in non-HDL and apoB. That is a meaningful, drug-adjacent effect from a fiber husk.

The broader claim, that high fiber intake is linked to lower all-cause mortality, is real but observational. Large pooled cohorts found the lowest risk around 25 to 29 grams of total fiber a day, with each extra 10 grams associated with roughly a 10 percent lower mortality risk. Important honesty: people who eat a lot of fiber differ in dozens of ways, so this is “associated with,” not “proven to cause.” Food first, psyllium as a supplement if you fall short. Titrate up slowly to avoid bloating, take it with plenty of water, and separate it from medications by a couple of hours.

Promising but unproven: the molecules the trials keep deflating

This is the tier the longevity influencers live in. The biology is genuinely interesting. The human results are genuinely underwhelming.

NMN and NR: NAD+ goes up, almost nothing else does

NAD+ is a coenzyme central to energy metabolism that declines with age. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors that reliably raise blood NAD+ in humans. That part is real and well-replicated. The problem is everything downstream.

For NR, the functional trials are overwhelmingly null. Gold-standard insulin sensitivity testing: null. Heart failure: NAD+ doubled, but ejection fraction, function, and quality of life did not budge. Muscle, cognition: null. The single most-hyped result, a small blood pressure drop, was a post-hoc subgroup in a 24-person crossover study with no published confirmation. A leading 2023 scientific review concluded NR “has displayed few clinically relevant effects” and warned of “an unfortunate tendency to exaggerate.” There is also a mouse study suggesting NR increased breast cancer brain metastasis; it was mouse-and-cell only and has not been studied in humans, but it is reason for caution if you have active cancer.

NMN has a similar story: one small trial showed improved muscle insulin sensitivity in prediabetic women, but no change in glucose, HbA1c, or lipids, and a 2024 meta-analysis of eight trials found no metabolic benefit. NMN also has a tangled regulatory history. In late 2022 the FDA ruled it could not be sold as a dietary supplement because it had been studied as a drug, and major retailers delisted it. Then in late 2025 the FDA reversed itself and declared NMN lawful again. So the accurate present-tense statement is that NMN is legally sold in the US again as of 2026, after a strange detour, not that it is banned.

If you want to experiment, treat it as exactly that: an experiment with a third-party-tested product, not a proven intervention.

Resveratrol: the cautionary tale of the whole field

Resveratrol launched the modern longevity supplement industry on the back of a 2003 study claiming it activated “longevity genes” (sirtuins). That finding was later shown to be largely an artifact of the lab assay, and the biotech company built on it (Sirtris, bought for around $720 million) was shut down by 2013. The killer practical fact: resveratrol has under 1 percent oral bioavailability. Your blood essentially never reaches the concentrations used in the cell studies. Human trials have been disappointing across the board, and an Alzheimer’s trial even showed greater brain-volume loss on the drug. This one is a skip.

Spermidine: the food beats the pill

Spermidine triggers autophagy (cellular cleanup) in animals, and a well-known observational study linked spermidine-rich diets to longer life. But that study is confounded: the people eating the most spermidine were eating whole grains and legumes, the whole healthy-diet package. When researchers ran an actual randomized trial, the SmartAge trial (JAMA Network Open, 2022, 100 older adults over 12 months), the memory benefit was flatly null. An earlier small positive pilot failed to replicate, the classic small-promising-then-larger-null pattern. European regulators have approved zero health claims for it. Eat the wheat germ, mushrooms, and legumes; skip the capsule.

Urolithin A: real biology, missed endpoints

Urolithin A (sold as Mitopure) promotes mitophagy, the recycling of worn-out mitochondria. Only about 40 percent of people make it naturally from dietary precursors, which is the legitimate rationale for supplementing. But the two big muscle trials, both manufacturer-funded, missed their primary endpoints. One (88 middle-aged adults) found no significant change in peak power output, its primary measure, and leaned on secondary strength numbers for its headline. Another (66 older adults) missed both primary endpoints; muscle endurance improved at two months but the placebo group caught up by four. It does reliably lower some inflammation markers. The honest verdict: interesting, early, and not yet backed by a clean functional win.

Taurine: a 2023 mouse headline, a 2025 human reversal

Taurine had a viral moment in 2023 when a Science paper showed that supplementing it extended median lifespan by about 10 to 12 percent in mice, improved healthspan markers in monkeys over six months (with no lifespan data), and noted that taurine levels appeared to decline with age in humans. The catch is what came next. In June 2025, a Science paper from an NIH group analyzed multiple human cohorts and found that circulating taurine did not consistently decline with age; it often stayed stable or rose. The authors concluded taurine is not a reliable aging biomarker and that the effects are “context-dependent.” A second 2025 study in 137 men reached the same conclusion. There is no human RCT showing taurine supplementation extends healthspan or lifespan, and the central human premise behind the hype was directly contradicted. For longevity specifically, this is a skip until real human trials exist.

Prescription only: rapamycin is not a supplement

Rapamycin (the drug sirolimus) is the molecule with arguably the strongest animal longevity evidence of anything here, and it is important to be clear that it is not a supplement and should never be self-sourced. It inhibits mTOR, a nutrient-sensing pathway, and in the rigorously replicated NIA Interventions Testing Program it extended mouse median lifespan by roughly 9 percent in males and 13 percent in females even when started in mid-to-late life. That is a landmark result in aging biology.

The human longevity evidence does not match the hype. A 2023 systematic review found rapamycin improved some aging-related markers in immune, cardiovascular, and skin systems but established no effect on human lifespan or healthspan. The most-cited human trial, PEARL (a 48-week randomized, placebo-controlled study in healthy adults published in 2024), missed its primary endpoint: visceral fat did not change significantly (p = 0.942). There were small, exploratory, women-only secondary signals for lean mass and pain, but those are hypothesis-generating, not proof.

Rapamycin is FDA-approved only to prevent organ-transplant rejection. Longevity use is entirely off-label. At higher doses it suppresses the immune system, raises infection risk, impairs wound healing, and can raise cholesterol and blood sugar. Absorption varies several-fold between individuals, which is exactly why it requires a physician and sometimes blood-level monitoring. If you are curious about it, that is a conversation with a doctor, not a purchase.

The boring stuff that works best

Here is the part the supplement economy would rather you skim past. The interventions with the strongest evidence for living longer and better are free, and they out-perform every molecule above by a wide margin.

Cardiorespiratory fitness is the single most striking predictor. In a Cleveland Clinic study of 122,007 adults (JAMA Network Open, 2018), the least-fit people had about five times the mortality risk of the most-fit (hazard ratio 5.04). To put that in perspective, in the same data being unfit carried a larger adjusted mortality association than smoking (1.41), diabetes (1.40), or coronary artery disease (1.29). And there was no upper limit; even “elite” fitness beat merely “high.” If you do one thing for longevity, raise your VO2max.

Exercise dose-response is generous. Meeting the standard guideline of about 150 minutes a week of moderate activity is associated with roughly a third lower mortality, with benefit continuing up to three to five times that amount. Resistance training adds its own independent benefit: any strength work is linked to about 15 percent lower all-cause mortality, with most of the gain arriving at just 30 to 60 minutes a week. Combining cardio and strength beats either alone.

Sleep follows a U-curve centered near 7 hours. Sleeping under 7 hours carries a modestly higher mortality risk, and over 9 hours a higher one still (partly because illness causes long sleep). Both short and long sleep also track with higher dementia risk.

Protein protects muscle as you age. The official RDA of 0.8 g/kg is widely considered too low for older adults; expert groups recommend 1.0 to 1.2 g/kg a day, and 1.2 g/kg or more for those who exercise. Pair adequate protein with resistance training and you have the single best defense against the muscle loss that drives frailty.

Don’t smoke, and rethink alcohol. Smoking costs roughly a decade of life expectancy, and quitting before 40 removes about 90 percent of the excess risk. As for alcohol, the old “a glass of red is good for your heart” story has collapsed; the apparent benefit was a statistical artifact of lumping sick ex-drinkers in with abstainers. The 2023 WHO position is blunt: there is no safe level. Less is better, none is best.

No capsule on the market competes with the effect size of fitness, sleep, protein, and not smoking. Spend there first.

Test, don’t guess

Here is the move that turns this entire debate from guesswork into something useful. Instead of stacking ten capsules and hoping, measure the markers that actually track with how you age, change one variable, and re-test in three to six months. That tells you what is working in your body, which no influencer’s stack can.

The handful of markers worth tracking for this purpose:

• Omega-3 index: tells you whether you even need fish oil, and whether your dose is working.
• Vitamin D (25-OH): the only honest way to know if you should supplement at all.
• ApoB: the best single number for cardiovascular risk, and the one psyllium and diet move.
• hs-CRP: a marker of systemic inflammation that several interventions (and fitness) lower.
• Fasting insulin: an early signal of metabolic trouble, often years before glucose moves.

Comprehensive at-home panels now cover all of these in one draw. Our guide to the best at-home biomarker tests walks through the options, and if you are weighing the two biggest names, see our Superpower vs Function Health comparison. The logic is simple: a single test that shows your omega-3 index is already 8 percent, or your vitamin D is fine, just saved you years of buying supplements you never needed.

Safety, interactions, and who should avoid these

“Natural” does not mean “harmless,” especially in this category. A few rules:

• High-dose omega-3 (above about 1 gram a day of EPA/DHA) raises atrial fibrillation risk and can increase bleeding. Be cautious if you have a heart-rhythm history or take blood thinners.
• Vitamin D at chronic high doses can cause hypercalcemia and, paradoxically, more falls. Dose to a blood level, do not megadose blindly.
• Magnesium can cause diarrhea (especially the oxide form) and accumulates dangerously in people with kidney impairment.
• Psyllium can interfere with the absorption of medications; take it a couple of hours apart, with plenty of water.
• CoQ10 can reduce the effect of the blood thinner warfarin.
• NAD+ precursors (NMN/NR) lack long-term human safety data, and people with active cancer should be cautious given the unresolved mechanistic questions.
• Rapamycin is a prescription immunosuppressant; never self-source it.

If you are pregnant or breastfeeding, on prescription medication, or managing a chronic condition, talk to a clinician before adding anything. This article is evidence-based education, not medical advice.

Frequently asked questions

Do any longevity supplements actually extend human lifespan?

No supplement has been proven to extend human lifespan in randomized trials. The realistic goal is supporting the systems that age first (cardiovascular, metabolic, muscle) and correcting genuine deficiencies. Most “lifespan extension” headlines come from mouse, worm, or cell studies that have not translated to humans.

What is the simplest evidence-based stack?

For most people: enough protein, omega-3 if your fish intake is low, and vitamin D if a blood test shows you are deficient. Add creatine if you do resistance training and psyllium if your LDL or fiber intake needs work. That covers the supplements with real human trial support. Everything else is optional experimentation.

Is NMN safe and is it still legal in the US?

Short-term human studies suggest NMN is generally well tolerated, but there is no long-term safety data. On legality: the FDA ruled in 2022 that NMN could not be sold as a supplement, then reversed that decision in late 2025. As of 2026 it is legally sold again. Choose third-party-tested products and check with a clinician if you take medications.

Should I take resveratrol?

Probably not. Resveratrol has under 1 percent oral bioavailability, the original “longevity gene” mechanism was largely an assay artifact, and human trials have been disappointing. The biology that launched the supplement industry did not hold up.

What about the taurine longevity studies?

A 2023 mouse study showed taurine extended lifespan in mice, which went viral. But a 2025 human study found that taurine levels do not consistently decline with age in people, contradicting the central premise, and there is no human trial showing supplementation extends healthspan. For longevity, the evidence does not support it yet.

Does creatine damage your kidneys?

For healthy people, no. The concern comes from creatine raising creatinine, a kidney marker, without causing actual damage. Standard 3 to 5 gram daily doses show no kidney or liver harm in healthy adults across many studies. People with pre-existing kidney disease should consult a doctor.

Is rapamycin a longevity supplement I can buy?

No. Rapamycin is a prescription immunosuppressant drug, not a supplement. It has strong mouse-lifespan data but unproven human longevity benefit (the PEARL trial missed its primary endpoint), and it carries real risks including immune suppression. It requires a physician; self-sourcing is unsafe.

How do I know which supplements I actually need?

Test before you guess. A blood panel covering omega-3 index, vitamin D, ApoB, hs-CRP, and fasting insulin tells you which deficiencies or risks you actually have, so you only supplement what moves your numbers. Re-test after a few months to confirm a change is working. See our at-home biomarker test guide for options.

Are urolithin A and NAD+ boosters worth trying?

They are reasonable experiments if you have money to spare and realistic expectations. Both reliably move a biomarker, but their big human trials have largely missed the functional endpoints that matter. Treat them as experiments with third-party-tested products, not proven interventions, and track your own markers to see if anything actually changes.

Can supplements replace exercise and sleep for longevity?

No, and it is not close. Cardiorespiratory fitness, resistance training, adequate sleep, enough protein, and not smoking have far larger evidence-backed effects on lifespan than any supplement. In one large study, low fitness carried a bigger mortality risk than smoking or diabetes. Spend your effort there first; supplements are the margin, not the main event.

Reviewed by the VST Editorial Board. Vital Signs Today publishes evidence-based health information and does not provide medical advice. Consult a qualified clinician before starting any supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.